To summarize six years of implementation, monitoring, and quality improvement of the 'Heroes in Motion' (HIM) exercise therapy program for pediatric oncology patients.
Key Findings:
457 patients aged 1-24 years participated in the HIM program over six years.
Completed 3,860 inpatient and 813 outpatient sessions.
Satisfaction rates increased from 74% in 2020 to 81% in 2025.
Participants reported benefits such as individualized care and motivation.
Demand for more frequent sessions and improved exercise facilities was expressed.
Interpretation:
The HIM program was well-accepted in a pediatric oncology setting, with ongoing structural development and increased family involvement.
Limitations:
No inferential statistical analyses or hypothesis testing were performed.
Data derived from routine documentation may have inherent biases.
Conclusion:
The HIM program provides insights into exercise therapy in supportive care for pediatric oncology patients.
Legend and Kelonia reveal 100 percent response rates in phase 1 trials, dual CAR T opens doors for kidney transplant patients, and iPDSC therapy beefs up failing hearts
